IMNM Financials
Immunome Inc - Financial statements & key metrics
Stock Price
$27.07
Market Cap
$2.47B
P/E Ratio
-5.4
EPS
$-2.96
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$9.04M
Gross Profit
-
Operating Income
-
Net Income
$-292.96M
EPS (Diluted)
$-5.00
Balance Sheet Highlights
Total Assets
$240.24M
Total Liabilities
$59.08M
Shareholders Equity
-
Cash & Equivalents
$143.35M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-110.79M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Operating Margin
-2137.1%
ROE
-93.0%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is IMNM revenue?
IMNM's most recent quarterly revenue was $9.04M. Annual revenue can be calculated by summing the four most recent quarters.
Is IMNM profitable?
IMNM reported a loss of $292.96M in the most recent quarter.
What is IMNM market cap?
IMNM has a market capitalization of $2.47B, making it a mid-cap stock.
Does IMNM have debt?
View IMNM's balance sheet for debt information.
What is IMNM cash flow?
Cash flow data is available in the full financial statements.